Abstract
The LGI1 gene has been implicated in the development of epilepsy and the invasion phenotype of glial cells. Controversy over the specific tissue expression pattern of this gene has stemmed from conflicting reports generated using immunohistochemistry and the polymerase chain reaction. LGI1 is one of a four-member family of secreted proteins with high homology and here we demonstrate, using GFP-tagged constructs from the four LGI1family members, that commonly used antibodies against LGI1 cross-react with different family members. With the uncertainty surrounding the use of commercially available antibodies to truly establish the expression pattern of LGI1, we generated transgenic mice carrying the LGI1-containing BAC, RP23-127G7, which had been modified to express the GFP reporter gene under the control of the endogenous regulatory elements required for LGI1 expression. Three founder mice were generated, and immunohistochemistry was used to determine the tissue-specific pattern of expression. In the brain, distinct regions of glial and neuronal cell expression were identified, as well as the choriod plexus, which is largely pia-derived. In addition, strong expression levels were identified in glandular regions of the prostate, individual tubules in the kidney, sympathetic ganglia in the kidney, sebaceous glands in the skin, the islets of Langerhans, the endometrium, and the ovary and testes. All other major organs analyzed were negative. The pattern of reporter gene expression was identical in three individual founder mice, arguing against a position effect altering expression profile due to the integration site of the BAC.
Similar content being viewed by others
References
Besleaga R, Montesinos-Rongen M, Perez-Tur J, Siebert R, Deckert M (2003) Expression of the LGI1 gene product in astrocytic gliomas: downregulation with malignant progression. Virchows Arch 43:561–564
Brodtkorb E, Nakken KO, Steinlein OK (2003) No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res 56:205–208
Buchanan SG, Gay NJ (1996) Structural and functional diversity in the leucine-rich repeat family of proteins. Prog Biophys Mol Biol 65:1–44
Chernova OB, Somerville RP, Cowell JK (1998) A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17:2873–2881
Cowell JK (2002) Epilepsy research gets new guidance. Nat Med 8:219–220
Dube DH, Bertozzi CB (2005) Glycans in cancer and inflammation – potential for therapeutics and diagnostics. Nat Rev Drug Discov 4:477–488
Gabellini N, Masola V, Quartesan S, Oselladore B, Nobile C, et al. (2006) Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. J Cell Physiol 207:711–721
Gong S, Zheng C, Doughty M, Losos K, Didkovsky N, et al. (2003) A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:917–925
Gu W, Brodtkorb E, Steinlein OK (2002a) LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 52:364–367
Gu W, Wevers A, Schroder H, Grzeschik KH, Derst C, et al. (2002b) The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins. FEBS Lett 519:71–76
Gu W, Brodtkorb E, Piepoli T, Finocchiaro G, Steinlein OK (2005) LGI1: a gene involved in epileptogenesis and glioma progression? Neurogenetics 6:59–66
Heintz N (2001) BAC to the future: the use of BAC transgenic mice for neuroscience research. Nat Rev Neurosci 12:861–870
Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, et al. (2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30:335–341
Krex D, Hauses M, Appelt H, Mohr B, Ehninger G, et al. (2002) Physical and functional characterization of the human LGI1 gene and its possible role in glioma development. Acta Neuropathol (Berl) 103:255–266
Kunapuli P, Chitta K, Cowell JK (2003) Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Oncogene 2:3985–3999
Kunapuli P, Kasyapa CS, Hawthorn L, Cowell JK (2004) LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J Biol Chem 279:23151–23157
Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, Saenz A, Poza JJ, et al. (2002) Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet 11:1119–1128
Ottman R, Winawer MR, Kalachikov S, Barker-Cummings C, Gilliam TC, et al. (2004) LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 62:1120–1126
Piepoli T, Jakupoglu C, Gu W, Lualdi E, Suarez-Merino B, et al. (2006) Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro-oncol 8:96–108
Reddy KB, Nabha SM, Atanaskovam N (2003) Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22:395–403
Rossi MR, Huntoon K, Cowell JK (2005) Differential expression of the LGI and SLIT families of genes in human cancer cells. Gene 356:85–90
Senechal KR, Thaller C, Noebels JL (2005) ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 14:1613–1620
Shevde LA, Welch DR (2003) Metastasis suppressor pathways—an evolving paradigm. Cancer Lett 198:1–20
Somerville RP, Chernova O, Liu S, Shoshan Y, Cowell JK (2000) Identification of the promoter, genomic structure, and mouse ortholog of LGI1. Mamm Genome 11:622–627
Sossey-Alaoui K, Ranalli TA, Li X, Bakin A, Cowell JK (2005) WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3 and MMP-9 expression. Exp Cell Res 308:135–145
Staub E, Perez-Tur J, Siebert R, Nobile C, Moschonas NK, et al. (2002) The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders. Trends Biochem Sci 27:441–444
Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3:55–63
Viala E, Pouyssegur J (2004) Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann N Y Acad Sci 1030:208–218
Acknowledgments
This work was supported by a National Cancer Institute, RPCI Cancer Center Support Grant CA 16056 and a National Institute of Neurological Disorders and Stroke grant NS046706 from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Head, K., Gong, S., Joseph, S. et al. Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome 18, 328–337 (2007). https://doi.org/10.1007/s00335-007-9024-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-007-9024-6